Further, genistein decreases phosphorylated-Akt in HT-29 colon cancer cells [192], in LNCaP prostate cancer cells [193], and in HeLa and CaSki cervical cancer cell lines [194], as well as in other cancer cell cultures [175]. Here, AKT1 is linked to colonic neoplasm.